title: Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.
abstract: Polycystic ovary syndrome (PCOS), a common endocrinopathy of women of reproductive age, is associated with the early appearance of multiple risk factors for cardiovascular disease, such as abdominal obesity, dyslipidemia, and diabetes mellitus. However, premature atherosclerosis of the carotid artery has not yet been demonstrated in young women with PCOS. Measurement of carotid intima-media thickness (IMT) is considered an easy and reliable index of subclinical atherosclerosis, which is predictive of subsequent myocardial infarction and stroke. To evaluate the cardiovascular risk of PCOS and the participation of the hyperandrogenemic and metabolic pattern, we measured carotid IMT by B-mode ultrasound as well as hormonal and several cardiovascular disease-associated parameters in 75 young women with PCOS and 55 healthy, age- and body mass index-matched women. The PCOS women had significantly increased carotid IMT (0.58 vs. 0.47 mm, P < 0.001) and abdominal adiposity; higher levels of androgens, insulin, homeostasis model assessment score of insulin sensitivity, and total and low-density lipoprotein-cholesterol; and significantly lower levels of SHBG and high-density lipoprotein-cholesterol. In the studied population (n = 130), PCOS status, age, body mass index, and parental history of coronary heart disease were strong positive predictors of carotid IMT, whereas dehydroepiandrosterone sulfate was a strong negative predictor. In PCOS patients lower delta4-androstenedione and high-density lipoprotein-cholesterol levels were additionally strong positive predictors of carotid IMT, whereas in control women only total cholesterol was the additional positive predictor of carotid IMT. In conclusion, young women with PCOS have an early increase of cardiovascular risk factors and greater carotid IMT, both of which may be responsible for subclinical atherosclerosis. The hyperandrogenemic phenotype of the syndrome may attenuate the consequences of the dysmetabolic phenotype on the vascular wall.
authors.affiliation: Department of Clinical Biochemistry, Athens University Medical School, Greece. mahi_vr@hotmail.com
authors.forename: Andromachi
authors.initials: A
authors.lastname: Vryonidou
authors.forename: Athanasios
authors.initials: A
authors.lastname: Papatheodorou
authors.forename: Anna
authors.initials: A
authors.lastname: Tavridou
authors.forename: Thomais
authors.initials: T
authors.lastname: Terzi
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Loi
authors.forename: Ioannis-Anastasios
authors.initials: IA
authors.lastname: Vatalas
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Batakis
authors.forename: Constantinos
authors.initials: C
authors.lastname: Phenekos
authors.forename: Amalia
authors.initials: A
authors.lastname: Dionyssiou-Asteriou
mesh_terms: D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D002339:Carotid Arteries / Q000473:pathology*; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000378:metabolism / Q000473:pathology*; D015999:Multivariate Analysis; D010641:Phenotype; D011085:Polycystic Ovary Syndrome / Q000378:metabolism / Q000473:pathology*; D011446:Prospective Studies; D017539:Tunica Intima / Q000473:pathology*
chemical_list: D019314:Dehydroepiandrosterone Sulfate